Export and regulated-market generics — large — Business MegaBrands 2026–27
This category covers Indian pharmaceutical companies that develop, file and manufacture generic medicines at scale for regulated markets such as the United States, Europe and Japan, alongside sales at home. Their plants operate under inspection by overseas regulators. The work earns export revenue for India and supplies lower-cost equivalents of off-patent drugs to health systems abroad.
Slot BMB-169 · Pharmaceuticals · 4 brands in contention · Business MegaBrand: to be announced in 2027
Brands in contention
Listed alphabetically. The order does not reflect evaluation.
| Company | MegaBrands 501 |
|---|---|
| Aurobindo Pharma | |
| Dr. Reddy's | Also a MegaBrand 501 |
| Hetero | |
| MSN Laboratories |
How this category is evaluated
Every brand in this category is assessed on WCRC's 50-parameter brand evaluation model, across five pillars: Brand Positioning & Recall, Trust & Sentiment, Product, Innovation & Delivery, Sustainability, Governance & ESG, and Digital & Financial Soundness. Scores are compared within the category, and the brand with the strongest result is named the Business MegaBrand. Read the methodology
Frequently asked
Which are the leading generic pharma companies in India for regulated markets?
In the Business MegaBrands 2026–27 cohort, the brands in contention for large export and regulated-market generics are Aurobindo Pharma, Dr. Reddy's, Hetero and MSN Laboratories. This is a list, not a ranking. WCRC will name one Business MegaBrand after its independent 50-parameter evaluation of every brand in contention.
Other categories in Pharmaceuticals
- Branded formulations — large
- Branded formulations — mid-size
- Branded formulations — specialty and challengers
- Export generics — mid-size
All of Pharma, Life Sciences & Medtech · The 2026–27 cohort
Cite this page: WCRC, Business MegaBrands 2026–27, Export and regulated-market generics — large (Slot BMB-169), https://www.mostvaluablebrands.com/business-megabrands/2026-27/pharma-life-sciences-and-medtech/export-and-regulated-market-generics-large/, accessed [date].
WCRC network: WCRC International · WCRC Leaders